Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by SPCEO1on Apr 19, 2021 12:44am
251 Views
Post# 33020254

My hoped for outcome

My hoped for outcomeI hope Dawn and Paul agree to speak with Wino. I hope they have a productive conversation where they acknowledge the concerns Wino shares with them are legitimate. I hope they share their plans with Wino and that Wino is able to offer them helpful insights to improve those plans. I hope Wino comes back from his call and tells us to chill out because what he heard convinces him they have sensible plans to get the share price more connected to the reality of the company's situation and more in line with its NASH and cancer peers. I need nothing other than that. If Wino is happy, I will likely be happy too. I don't need any specifics because I trust Wino's judgment. If things get ugly, which they most certainly shouldn't, and I feel the need to disappear from Stockhouse then you all will know that I am likely going to vote the shares I control against all of the directors. By doing that I will effectively be turning over to the rest of you to pick who you want to vote off the board. Since we are likely the swing votes, whoever you all agree to vote off would not be likely to able to win outside of a really heroic effort by TH to solicit proxy votes from those shareholders who normally don't vote. Hopefully, we soon hear from Wino that he is convinced the current board has things on a good course and we can go back to focusing on cancer and NASH.
<< Previous
Bullboard Posts
Next >>